+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Single Cell Sequencing Market - Global Forecast to 2030- Product Image
Single Cell Sequencing Market - Global Forecast to 2030- Product Image
Sale

Single Cell Sequencing Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011741
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Single Cell Sequencing Market grew from USD 2.64 billion in 2024 to USD 2.77 billion in 2025. It is expected to continue growing at a CAGR of 4.90%, reaching USD 3.52 billion by 2030.

Executive Overview and Scope of Single Cell Sequencing

Single cell sequencing has emerged as a paradigm-shifting technology that dissects biological complexity at unprecedented resolution. By enabling the analysis of genomic, transcriptomic, and epigenomic profiles in individual cells, it reveals heterogeneity concealed by bulk measurements and accelerates discoveries across cancer biology, immunology, neuroscience, and regenerative medicine. This executive summary outlines recent innovations, regulatory headwinds, segmentation nuances, regional dynamics, and competitive landscapes that define the current state of single cell sequencing. By synthesizing transformative shifts in instrumentation, methodologies, and bioinformatics, it equips decision-makers with actionable insights to navigate market challenges and capitalize on emerging opportunities. The following sections explore key drivers reshaping the industry, the potential ramifications of upcoming tariffs in the United States, granular segmentation trends, regional priorities, leading technology providers, and strategic recommendations for stakeholders poised to advance single cell technologies.

Key Transformative Shifts Shaping Single Cell Sequencing

Single cell sequencing has undergone rapid evolution in recent years, driven by breakthroughs in microfluidics, droplet-based partitioning, and high-throughput sequencing platforms. The integration of multi-omics capabilities now allows simultaneous profiling of DNA, RNA, proteins, and chromatin accessibility within individual cells, ushering in an era of true cellular phenotyping. Cloud-native bioinformatics pipelines and artificial intelligence-enhanced data analysis frameworks have reduced time-to-insight, enabling real-time decision-making in clinical and research settings. At the same time, cost reductions in reagent formulations and sample preparation systems have democratized access, accelerating adoption among academic laboratories, contract research organizations, and biopharmaceutical companies. These shifts collectively transform single cell sequencing from a niche research tool into a mainstream platform for precision medicine, disease modeling, and biomarker discovery.

Assessing the Cumulative Impact of United States Tariffs 2025 on Single Cell Sequencing

Proposed United States tariffs slated for 2025 target a variety of laboratory instruments and reagents critical to single cell workflows, introducing potential cost escalations and supply chain disruptions. Equipment manufacturers that import sequencing systems, microfluidic devices, and data analysis platforms could face duty hikes that diminish profit margins or prompt price increases for end users. Reagent and kit providers may experience higher input costs for amplification kits, library preparation consumables, and specialized flow cells sourced from overseas suppliers. These tariff-induced pressures could shift procurement strategies toward regional vendors, accelerate localization of manufacturing, and incentivize vertical integration. While higher prices may temper adoption in cost-sensitive segments, they also create opportunities for domestic producers and contract manufacturing organizations to expand capacity and secure alternative sourcing agreements.

Revealing Critical Market Segmentation Insights

Market segmentation offers a lens to understand how technological, application, end-user, cell type, and workflow variations shape priorities and investments. When examining technology type, instruments are evolving beyond sequencing systems to encompass advanced sample preparation systems and robust data analysis platforms that streamline end-to-end workflows, while reagents and kits now feature highly optimized library preparation kits, amplification chemistries, and precision-engineered flow cells; sequencing platforms advance both next-generation and legacy Sanger approaches to meet diverse throughput and read-length requirements. From an application standpoint, cancer research drives the highest demand, with immuno-oncology assays and tumor profiling tools converging with molecular diagnostics, whereas epigenomics workflows unravel chromatin accessibility, DNA methylation, and histone modification patterns. Neurological research emphasizes single cell investigations into neurodegenerative and neurodevelopmental disorders, and stem cell research leverages differentiation assays and gene editing validation protocols. Evaluating end users uncovers critical distinctions: academic and research institutes invest heavily in foundational biology studies via research foundations and university laboratories; contract research organizations focus on clinical trial support and outsourced research; hospitals and diagnostic laboratories deploy clinical diagnostic and pathology labs for translational applications; and pharmaceutical and biotech companies integrate single cell insights into biopharmaceutical manufacturing and drug development pipelines. Cell type segmentation spotlights carcinoma and leukemia cell profiling within cancer cells, advanced immunophenotyping of B cells, T cells, and natural killer cells, neuron subtype analysis of motor and sensory neurons, and differentiation tracking in adult and pluripotent stem cells. Workflow segmentation highlights data analysis as a growth driver with bioinformatics tools and computational model innovations, sample preparation enhancements through refined cell isolation and lysis protocols, and sequencing modules optimized for library construction and execution.

Unveiling Regional Dynamics in Single Cell Sequencing

Regional dynamics significantly influence adoption rates, regulatory frameworks, and investment priorities in single cell sequencing. In the Americas, strong venture capital flows and established life science clusters support rapid deployment of cutting-edge instruments, while reimbursement policies in clinical diagnostics drive translational applications. Europe, the Middle East & Africa benefit from coordinated research initiatives, pan-European funding mechanisms, and diversified government support that foster collaborative consortia, although regulatory heterogeneity across jurisdictions adds complexity to cross-border studies. Asia-Pacific leads in manufacturing scale and cost-effective production of reagents and consumables, supported by robust domestic demand in research institutes and pharmaceutical enterprises, while emerging economies increasingly adopt single cell technologies to address region-specific healthcare challenges. These regional nuances shape supply chain strategies, partnership models, and go-to-market approaches for equipment vendors and service providers looking to establish or expand their footprint.

Profiling Leading Players Driving Innovation

The competitive landscape features a blend of established multinationals and innovative disruptors pushing the frontiers of single cell analysis. Companies such as 10x Genomics, Inc. lead with high-throughput droplet-based solutions and comprehensive sample-to-answer workflows, whereas Illumina, Inc. continues to dominate sequencing throughput with scalable platforms that address large-scale projects. Agilent Technologies, Inc. and Danaher Corporation deliver complementary instrumentation and automation systems that streamline sample preparation and quality control. Bio-Rad Laboratories, Inc. and BGI Genomics Co. Ltd. innovate in specialized reagent kits and library construction chemistries, while Oxford Nanopore Technologies PLC advances real-time, long-read sequencing for complex transcriptomic and epigenomic profiling. Merck KGaA integrates critical reagents for amplification and flow cell manufacturing, while Qiagen N.V. and PerkinElmer, Inc. bring robust molecular diagnostics and workflow optimization tools to clinical and research laboratories. Becton, Dickinson, and Company and DNA Electronics Ltd. introduce microfluidic and semiconductor-based systems to miniaturize assays, and mission-driven firms such as Mission Bio and Standard BioTools Inc. pioneer single cell proteomics and spatial omics integration. Roche (F. Hoffmann-La Roche Ltd.) and Danaher also leverage global service networks and strategic acquisitions to accelerate technology adoption.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize integration of multi-omics capabilities within unified platforms, fostering collaboration between instrument manufacturers and bioinformatics software providers to deliver seamless data pipelines. Building resilient supply chains requires establishing regional manufacturing hubs and diversifying raw material sources to mitigate tariff-driven cost fluctuations. Investment in artificial intelligence and machine learning will enhance automated cell classification, anomaly detection, and predictive modeling, delivering actionable insights faster and more accurately. Strategic partnerships with clinical centers and research consortia can validate novel assays, facilitate regulatory approvals, and strengthen adoption in translational and diagnostic settings. Companies should also expand flexible service offerings such as decentralized sequencing and remote analysis support to address evolving customer needs. Finally, proactive workforce development initiatives-training next-generation bioinformaticians and lab technicians-will ensure end users maximize the value of complex single cell data outputs.

Concluding Insights on Future Directions

Single cell sequencing continues its trajectory from bench to bedside, transforming our understanding of cellular heterogeneity and disease mechanisms. The convergence of advanced microfluidics, integrated multi-omics, cloud-native analytics, and AI-driven interpretation has unlocked new frontiers in personalized medicine, drug discovery, and fundamental biology. As technology platforms mature, collaboration across stakeholders-vendors, research institutes, clinical organizations, and regulatory bodies-will be essential to overcome cost barriers, standardize protocols, and ensure data interoperability. The cumulative impact of tariffs underscores the need for adaptive supply chain strategies and localized production capabilities. By aligning technological innovation with strategic partnerships and targeted investments, stakeholders can accelerate translational breakthroughs and consolidate single cell sequencing as a cornerstone of next-generation life science research and clinical applications.

Market Segmentation & Coverage

This research report categorizes the Single Cell Sequencing Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Instruments
    • Data Analysis Platforms
    • Sample Preparation Systems
    • Sequencing Systems
  • Reagents and Kits
    • Amplification Kits
    • Flow Cells
    • Library Preparation Kits
  • Sequencing Platforms
    • Next-Generation Sequencing
    • Sanger Sequencing
  • Cancer Research
    • Immuno-Oncology
    • Molecular Diagnostics
    • Tumor Profiling
  • Epigenomics
    • Chromatin Accessibility
    • DNA Methylation
    • Histone Modification
  • Neurological Research
    • Neurodegenerative Disorders
    • Neurodevelopmental Disorders
  • Stem Cell Research
    • Cell Differentiation
    • Gene Editing
  • Academic and Research Institutes
    • Research Foundations
    • University Laboratories
  • Contract Research Organizations
    • Clinical Trials
    • Outsourced Research
  • Hospitals and Diagnostic Laboratories
    • Clinical Diagnostic Labs
    • Pathology Labs
  • Pharmaceutical and Biotechnology Companies
    • Biopharmaceutical Manufacturing
    • Drug Development
  • Cancer Cells
    • Carcinoma Cells
    • Leukemia Cells
  • Immune Cells
    • B Cells
    • Natural Killer Cells
    • T Cells
  • Neurons
    • Motor Neurons
    • Sensory Neurons
  • Stem Cells
    • Adult Stem Cells
    • Pluripotent Stem Cells
  • Data Analysis
    • Bioinformatics Tools
    • Computational Models
  • Sample Preparation
    • Cell Isolation Techniques
    • Lysis and Amplification
  • Sequencing
    • Library Construction
    • Sequencing Execution

This research report categorizes the Single Cell Sequencing Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Single Cell Sequencing Market to delves into recent significant developments and analyze trends in each of the following companies:

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson, and Company
  • BGI Genomics Co. Ltd.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DNA Electronics Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Merck KGaA
  • Mission Bio
  • Oxford Nanopore Technologies PLC
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • Standard BioTools Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Single Cell Sequencing Market, by Technology Type
8.1. Introduction
8.2. Instruments
8.2.1. Data Analysis Platforms
8.2.2. Sample Preparation Systems
8.2.3. Sequencing Systems
8.3. Reagents and Kits
8.3.1. Amplification Kits
8.3.2. Flow Cells
8.3.3. Library Preparation Kits
8.4. Sequencing Platforms
8.4.1. Next-Generation Sequencing
8.4.2. Sanger Sequencing
9. Single Cell Sequencing Market, by Application
9.1. Introduction
9.2. Cancer Research
9.2.1. Immuno-Oncology
9.2.2. Molecular Diagnostics
9.2.3. Tumor Profiling
9.3. Epigenomics
9.3.1. Chromatin Accessibility
9.3.2. DNA Methylation
9.3.3. Histone Modification
9.4. Neurological Research
9.4.1. Neurodegenerative Disorders
9.4.2. Neurodevelopmental Disorders
9.5. Stem Cell Research
9.5.1. Cell Differentiation
9.5.2. Gene Editing
10. Single Cell Sequencing Market, by End User
10.1. Introduction
10.2. Academic and Research Institutes
10.2.1. Research Foundations
10.2.2. University Laboratories
10.3. Contract Research Organizations
10.3.1. Clinical Trials
10.3.2. Outsourced Research
10.4. Hospitals and Diagnostic Laboratories
10.4.1. Clinical Diagnostic Labs
10.4.2. Pathology Labs
10.5. Pharmaceutical and Biotechnology Companies
10.5.1. Biopharmaceutical Manufacturing
10.5.2. Drug Development
11. Single Cell Sequencing Market, by Cell Type
11.1. Introduction
11.2. Cancer Cells
11.2.1. Carcinoma Cells
11.2.2. Leukemia Cells
11.3. Immune Cells
11.3.1. B Cells
11.3.2. Natural Killer Cells
11.3.3. T Cells
11.4. Neurons
11.4.1. Motor Neurons
11.4.2. Sensory Neurons
11.5. Stem Cells
11.5.1. Adult Stem Cells
11.5.2. Pluripotent Stem Cells
12. Single Cell Sequencing Market, by Workflow
12.1. Introduction
12.2. Data Analysis
12.2.1. Bioinformatics Tools
12.2.2. Computational Models
12.3. Sample Preparation
12.3.1. Cell Isolation Techniques
12.3.2. Lysis and Amplification
12.4. Sequencing
12.4.1. Library Construction
12.4.2. Sequencing Execution
13. Americas Single Cell Sequencing Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Single Cell Sequencing Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Single Cell Sequencing Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. 10x Genomics, Inc.
16.3.2. Agilent Technologies, Inc.
16.3.3. Becton, Dickinson, and Company
16.3.4. BGI Genomics Co. Ltd.
16.3.5. Bio-Rad Laboratories, Inc.
16.3.6. Danaher Corporation
16.3.7. DNA Electronics Ltd.
16.3.8. F. Hoffmann-La Roche Ltd.
16.3.9. Illumina, Inc.
16.3.10. Merck KGaA
16.3.11. Mission Bio
16.3.12. Oxford Nanopore Technologies PLC
16.3.13. PerkinElmer, Inc.
16.3.14. Qiagen N.V.
16.3.15. Standard BioTools Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. SINGLE CELL SEQUENCING MARKET MULTI-CURRENCY
FIGURE 2. SINGLE CELL SEQUENCING MARKET MULTI-LANGUAGE
FIGURE 3. SINGLE CELL SEQUENCING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CELL TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY WORKFLOW, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY WORKFLOW, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. SINGLE CELL SEQUENCING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. SINGLE CELL SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SINGLE CELL SEQUENCING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY DATA ANALYSIS PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY AMPLIFICATION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY FLOW CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNO-ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY TUMOR PROFILING, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY EPIGENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CHROMATIN ACCESSIBILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY DNA METHYLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY HISTONE MODIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NEURODEVELOPMENTAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CELL DIFFERENTIATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY STEM CELL RESEARCH, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY RESEARCH FOUNDATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY UNIVERSITY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY OUTSOURCED RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTIC LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CARCINOMA CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY LEUKEMIA CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER CELLS, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNE CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY B CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NATURAL KILLER CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY T CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NEURONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY MOTOR NEURONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY SENSORY NEURONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NEURONS, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY ADULT STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PLURIPOTENT STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY BIOINFORMATICS TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY COMPUTATIONAL MODELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CELL ISOLATION TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY LYSIS AND AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY LIBRARY CONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCING EXECUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY STEM CELL RESEARCH, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER CELLS, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY NEURONS, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY STEM CELL RESEARCH, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER CELLS, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY NEURONS, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY STEM CELL RESEARCH, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER CELLS, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY NEURONS, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 158. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 159. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 160. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 161. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2030 (USD MILLION)
TABLE 162. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 164. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2030 (USD MILLION)
TABLE 165. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 166. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY STEM CELL RESEARCH, 2018-2030 (USD MILLION)
TABLE 167. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 169. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 170. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 171. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 172. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 173. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER CELLS, 2018-2030 (USD MILLION)
TABLE 174. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 175. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY NEURONS, 2018-2030 (USD MILLION)
TABLE 176. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 177. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 178. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 179. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 180. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 181. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 182. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 183. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 184. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2030 (USD MILLION)
TABLE 185. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 187. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2030 (USD MILLION)
TABLE 188. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 189. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY STEM CELL RESEARCH, 2018-2030 (USD MILLION)
TABLE 190. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 192. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 193. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 194. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 195. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 196. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER CELLS, 2018-2030 (USD MILLION)
TABLE 197. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 198. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY NEURONS, 2018-2030 (USD MILLION)
TABLE 199. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 200. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 201. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 202. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 203. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 204. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 205. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 206. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 207. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2030 (USD MILLION)
TABLE 208. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 210. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2030 (USD MILLION)
TABLE 211. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 212. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY STEM CELL RESEARCH, 2018-2030 (USD MILLION)
TABLE 213. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 215. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 216. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 217. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 218. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 219. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER CELLS, 2018-2030 (USD MILLION)
TABLE 220. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 221. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY NEURONS, 2018-2030 (USD MILLION)
TABLE 222. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 223. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 224. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 225. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 226. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 227. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 228. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 229. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 230. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY STEM CELL RESEARCH, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER CELLS, 2018-2030 (USD MILLION)
TABLE 244. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 245. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY NEURONS, 2018-2030 (USD MILLION)
TABLE 246. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 247. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 248. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 249. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 250. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 251. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 252. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 253. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 254. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 255. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2030 (USD MILLION)
TABLE 256. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 258. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2030 (USD MILLION)
TABLE 259. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 260. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY STEM CELL RESEARCH, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER CELLS, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY NEURONS, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 271. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 272. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 273. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 274. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 275. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 276. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 277. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 278. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2030 (USD MILLION)
TABLE 279. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 281. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2030 (USD MILLION)
TABLE 282. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 283. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY STEM CELL RESEARCH, 2018-2030 (USD MILLION)
TABLE 284. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 286. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 287. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 288. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 289. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 290. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER CELLS, 2018-2030 (USD MILLION)
TABLE 291. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 292. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY NEURONS, 2018-2030 (USD MILLION)
TABLE 293. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 294. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 295. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 296. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 297. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 298. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 299. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 300. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 301. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2030 (USD MILLION)
TABLE 302. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 303. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 304. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2030 (USD MILLION)
TABLE 305. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 306. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY STEM CELL RESEARCH, 2018-2030 (USD MILLION)
TABLE 307. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 309. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 310. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 311. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 312. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 313. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER CELLS, 2018-2030 (USD MILLION)
TABLE 314. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 315. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY NEURONS, 2018-2030 (USD MILLION)
TABLE 316. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 317. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 318. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 319. INDIA SINGLE CELL SEQUENCING

Companies Mentioned

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson, and Company
  • BGI Genomics Co. Ltd.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DNA Electronics Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Merck KGaA
  • Mission Bio
  • Oxford Nanopore Technologies PLC
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • Standard BioTools Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Single Cell Analysis Market - Global Forecast to 2030 - Product Image

Single Cell Analysis Market - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
Single-cell Analysis Market Size, Share & Trends Analysis Report by Product (Consumables, Instruments), Application (Cancer, Stem Cell), Workflow (Downstream Analysis, Data Analysis), End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Single-cell Analysis Market Size, Share & Trends Analysis Report by Product (Consumables, Instruments), Application (Cancer, Stem Cell), Workflow (Downstream Analysis, Data Analysis), End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
RNA Analysis / Transcriptomics - Global Strategic Business Report - Product Image

RNA Analysis / Transcriptomics - Global Strategic Business Report

  • Report
  • 504 Pages
  • Global
From
Single-Cell Genome Sequencing - Global Strategic Business Report - Product Image

Single-Cell Genome Sequencing - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.